676 results on '"Onal, Cem"'
Search Results
52. 348: Dosimetric comparison of helical tomotherapy plans in breast cancer patients with silicone implants
53. 131: Long-term assessment of clinical and PET parameters in predicting recurrence in cervical cancer
54. Radiotherapy in the Management of Testicular Cancers
55. Bladder Preservation Therapies in Bladder Cancer
56. Re-irradiation in Prostate Cancer
57. Advanced Radiotherapy Techniques in Prostate Cancer
58. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience
59. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy. In regard to Vojtíšek et al.
60. Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
61. Treatment outcomes of prostate cancer patients with Gleason score 8–10 treated with definitive radiotherapy: TROD 09-001 multi-institutional study
62. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study
63. Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients – A closer inspection will improve your vision
64. Innovations in Cervical Cancer Treatment—There is Still Room for Improvement
65. Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients
66. Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer
67. The impact of margin reduction on radiation dose distribution of ultra‐hypofractionated prostate radiotherapy utilizing a 1.5‐T MR‐Linac.
68. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis
69. Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated arc therapy, and helical tomotherapy for postoperative gastric cancer patients
70. Dosimetric analysis of testicular doses in prostate intensity-modulated and volumetric-modulated arc radiation therapy at different energy levels
71. Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
72. Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis
73. The significance of metabolic response to neoadjuvant androgen deprivation therapy detected with [68Ga]Ga-PSMA-11-PET/CT in high-risk prostate cancer patients treated with definitive radiotherapy.
74. PHARMACOKINETIC ANALYSIS OF FEBUXOSTAT IN HUMAN SERUM BY UFLC BASED ON FLUORIMETRIC DERIVATIZATION.
75. Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer
76. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study
77. In Regard to Hammer et al.
78. Dosimetric Evaluation of Ultra-Hypofractioanted Prostate Radiotherapy Using 1.5-Tesla MR-Linac and Conventional Linac
79. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy
80. Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy
81. Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma
82. Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study
83. Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy
84. The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer
85. Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?
86. The utility of 1.5 tesla MR-guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor – Case reports and review of the literature
87. P9.25: Stereotactic Ablative Body Radiotherapy as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: BaşKent University Experience
88. Cardiac angiosarcoma treated with 1.5 Tesla MR-guided adaptive stereotactic body radiotherapy – Case report and review of the literature
89. Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002
90. Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
91. The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy
92. Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach
93. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy
94. Graves’ ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature
95. Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02)
96. Ultra fast liquid chromatographic analysis of nonsteroidal anti-inflammatory drugs with fluorimetric detection in tap water, urine, and pharmaceutical samples
97. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy
98. There is no doubt about the winner of the lion–rabbit fight
99. 365: Ultrafractionated RT for prostate cancer: Dose escalation using MR-Linac
100. 126: The impact of dose-escalated RT on ADT in patients with intermediate risk prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.